Basic Information
Savene
Regulatory Information
EMEA/H/C/000682
Authorised
July 27, 2006
15
September 6, 2024
Company Information
Ireland
5th Floor Rear Connaught House 1 Burlington Road Dublin 4 Dublin
CNX THERAPEUTICS IRELAND LIMITED
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Savene is indicated for the treatment of anthracycline extravasation.
Overview Summary
This is a summary of the European public assessment report (EPAR) for Savene. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Savene.